Bone-targeted methotrexate–alendronate conjugate inhibits osteoclastogenesis in vitro and prevents bone loss and inflammation of collagen-induced arthritis in vivo

Rheumatoid arthritis (RA), a disease that causes joint destruction and bone erosion, is related to osteoclast activity. RA is generally treated with methotrexate (MTX). In this study, a MTX–Alendronate (ALN) conjugate was synthesized and characterized. The conjugate dramatically inhibited osteoclast...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Zi’ang, Liu, Guanxiong, Tang, Pan, Sun, Xuewu, Chen, Shuai, Qin, An, Zhu, Peizhi, Zhang, Jianfeng, Fan, Shunwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058523/
https://www.ncbi.nlm.nih.gov/pubmed/29303005
http://dx.doi.org/10.1080/10717544.2017.1422295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058523/
https://www.ncbi.nlm.nih.gov/pubmed/29303005
http://dx.doi.org/10.1080/10717544.2017.1422295

Ejemplares similares